Background: Coffee consumption has been shown to be associated with various health outcomes in observational studies. However, evidence for its association with epithelial ovarian cancer (EOC) is inconsistent and it is unclear whether these associations are causal. Methods: We used single nucleotide polymorphisms associated with (i) coffee and (ii) caffeine consumption to perform Mendelian randomization (MR) on EOC risk. We conducted a two-sample MR using genetic data on 44 062 individuals of European ancestry from the Ovarian Cancer Association Consortium (OCAC), and combined instrumental variable estimates using a Wald-type ratio estimator. Results: For all EOC cases, the causal odds ratio (COR) for genetically predicted consumption of one additional cup of coffee per day was 0.92 [95% confidence interval (CI): 0.79, 1.06]. The COR was 0.90 (95% CI: 0.73, 1.10) for high-grade serous EOC. The COR for genetically predicted consumption of an additional 80 mg caffeine was 1.01 (95% CI: 0.92, 1.11) for all EOC cases and 0.90 (95% CI: 0.73, 1.10) for high-grade serous cases. Conclusions: We found no evidence indicative of a strong association between EOC risk and genetically predicted coffee or caffeine levels. However, our estimates were not statistically inconsistent with earlier observational studies and we were unable to rule out small protective associations.
Background: Coffee consumption has been shown to be associated with various health outcomes in observational studies. However, evidence for its association with epithelial ovarian cancer (EOC) is inconsistent and it is unclear whether these associations are causal. Methods: We used single nucleotide polymorphisms associated with (i) coffee and (ii) caffeine consumption to perform Mendelian randomization (MR) on EOC risk. We conducted a two-sample MR using genetic data on 44 062 individuals of European ancestry from the Ovarian Cancer Association Consortium (OCAC), and combined instrumental variable estimates using a Wald-type ratio estimator. Results: For all EOC cases, the causal odds ratio (COR) for genetically predicted consumption of one additional cup of coffee per day was 0.92 [95% confidence interval (CI): 0.79, 1.06]. The COR was 0.90 (95% CI: 0.73, 1.10) for high-grade serous EOC. The COR for genetically predicted consumption of an additional 80 mg caffeine was 1.01 (95% CI: 0.92, 1.11) for all EOC cases and 0.90 (95% CI: 0.73, 1.10) for high-grade serous cases. Conclusions: We found no evidence indicative of a strong association between EOC risk and genetically predicted coffee or caffeine levels. However, our estimates were not statistically inconsistent with earlier observational studies and we were unable to rule out small protective associations.
Authors: Patrick Sulem; Daniel F Gudbjartsson; Frank Geller; Inga Prokopenko; Bjarke Feenstra; Katja K H Aben; Barbara Franke; Martin den Heijer; Peter Kovacs; Michael Stumvoll; Reedik Mägi; Lisa R Yanek; Lewis C Becker; Heather A Boyd; Simon N Stacey; G Bragi Walters; Adalbjorg Jonasdottir; Gudmar Thorleifsson; Hilma Holm; Sigurjon A Gudjonsson; Thorunn Rafnar; Gyda Björnsdottir; Diane M Becker; Mads Melbye; Augustine Kong; Anke Tönjes; Thorgeir Thorgeirsson; Unnur Thorsteinsdottir; Lambertus A Kiemeney; Kari Stefansson Journal: Hum Mol Genet Date: 2011-02-28 Impact factor: 6.150
Authors: Sanna Lensu; Jouni T Tuomisto; Jouko Tuomisto; Matti Viluksela; Marjo Niittynen; Raimo Pohjanvirta Journal: Toxicol Lett Date: 2011-03-31 Impact factor: 4.372
Authors: Yoon Ju Song; Alan R Kristal; Kristine G Wicklund; Kara L Cushing-Haugen; Mary Anne Rossing Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-03 Impact factor: 4.254
Authors: Natalie A Lueth; Kristin E Anderson; Lisa J Harnack; Jayne A Fulkerson; Kim Robien Journal: Cancer Causes Control Date: 2008-08-14 Impact factor: 2.506
Authors: Wolfgang W Huber; Gerlinde Scharf; Georg Nagel; Sonja Prustomersky; Rolf Schulte-Hermann; Bernd Kaina Journal: Mutat Res Date: 2003-01-28 Impact factor: 2.433